Ohio § 3701.88 340B covered entity reporting requirements

Ohio Statutes

§ 3701.88 — 340B covered entity reporting requirements

Ohio § 3701.88

Title 37Health-Safety-Morals

Ch. 3701Department of Health

This text of Ohio § 3701.88 (340B covered entity reporting requirements) is published on Counsel Stack Legal Research, covering Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ohio Rev. Code Ann. § 3701.88 (2026).

Text

(A)As used in this section: "340B covered entity" means an entity described in section 340B(a)(4) of the "Public Health Service Act," 42 U.S.C. 256b(a)(4). "340B drug" means a covered outpatient drug that has been subject to discount pricing under the 340B drug pricing program and is purchased by a 340B covered entity. "340B drug pricing program" means the federal drug pricing program established under 42 U.S.C. 256b. "Contract pharmacy" means a retail pharmacy under contract with a 340B covered entity to provide 340B drugs to patients on behalf of that covered entity under the 340B drug discount program or contract pharmacy on behalf of the covered entity.

(B)Not later than July 1, 2026, and not later than the first day of July in each year thereafter, each 340B covered entity shal

Free access — add to your briefcase to read the full text and ask questions with AI

(A) As used in this section:

"340B covered entity" means an entity described in section 340B(a)(4) of the "Public Health Service Act," 42 U.S.C. 256b(a)(4).

"340B drug" means a covered outpatient drug that has been subject to discount pricing under the 340B drug pricing program and is purchased by a 340B covered entity.

"340B drug pricing program" means the federal drug pricing program established under 42 U.S.C. 256b.

"Contract pharmacy" means a retail pharmacy under contract with a 340B covered entity to provide 340B drugs to patients on behalf of that covered entity under the 340B drug discount program or contract pharmacy on behalf of the covered entity.

(B) Not later than July 1, 2026, and not later than the first day of July in each year thereafter, each 340B covered entity shall submit a report to the department of health. The report shall be submitted in the form and manner specified by the department, in consultation with any other agency the department of health determines appropriate. The report shall contain all of the following information from the previous calendar year:

(1) All of the following data, delineated by patient payor type, including private insurance, medicare, medicaid, other third-party payor, uninsured, or self-pay:

(a) The aggregate acquisition cost for all 340B drugs dispensed or administered by the covered entity, associated facility, or contract pharmacy;

(b) The aggregate payments received from third-party payors, including insurers, for all 340B drugs dispensed or administered by the covered entity, associated facility, or contract pharmacy;

(c) The total number of prescriptions dispensed or administered by the covered entity, associated facility, or contract pharmacy, and the percentage of that total number that were 340B drugs ;

(2) In connection with administering and providing services under the 340B drug pricing program, the total payments made by the covered entity to contract pharmacies, third-party administrators, or any other party or entity.

(4) Information regarding the covered entity's contract pharmacies, including all of the following:

(a) The covered entity's total number of contract pharmacies;

(b) The total number of the covered entity's prescriptions that were filled at a contract pharmacy.

(5) A detailed accounting of the covered entity's expenditures from 340B drug pricing program profits, including all programs, services, and equipment funded or purchased with those profits.

(C) The department of health shall post the information in the reports required under this section on its public web site.

Last updated August 18, 2025 at 5:26 PM